Blood Cancer

As the 10th most common cancer in the United States, leukemia will affect up to 2 percent of Americans at some point in their lifetime.

DNA within the core of our cells is vulnerable to harmful insults. Many people are unaware that our DNA may be altered by a COVID-19 infection or vaccination.

Pepaxto was deemed to have ‘potential detriment in overall survival’ in patients in a phase 3 trial, prompting the FDA’s decision.

Clinical trial findings showed both treatments could reduce pain from vaso-occlusive events, hallmarks of sickle cell disease.

“It’s not about winning, it’s about what can be done through the collective efforts of a team,” Jennifer Taggart told me when we met in Hauppauge Long Island recently.

As the 10th most common cancer in the United States, leukemia will affect up to 2 percent of Americans at some point in their lifetime.

DNA within the core of our cells is vulnerable to harmful insults. Many people are unaware that our DNA may be altered by a COVID-19 infection or vaccination.

Pepaxto was deemed to have ‘potential detriment in overall survival’ in patients in a phase 3 trial, prompting the FDA’s decision.

Clinical trial findings showed both treatments could reduce pain from vaso-occlusive events, hallmarks of sickle cell disease.

“It’s not about winning, it’s about what can be done through the collective efforts of a team,” Jennifer Taggart told me when we met in Hauppauge Long Island recently.